comparemela.com

Latest Breaking News On - Medicines development for global health - Page 4 : comparemela.com

Nominations open in recognition and celebration of life science leaders

Abu Dhabi initiative treats 117 9 million against polio, neglected tropical diseases

Abu Dhabi: An Abu Dhabi-led programme has treated a total of 117.9 million individuals across the world against polio and Neglected Tropical Diseases (NTDs). Initiated by His Highness Sheikh Mohamed bin Zayed Al Nahyan, Abu Dhabi Crown Prince and Deputy Supreme Commander of the UAE Armed Forces, the Reaching the Last Mile (RLM) Initiative has also trained more than 715,000 health workers, and administered 523.5 million immunisations and medications, in an effort to end preventable diseases that affect the world’s poorest and most vulnerable communities. All at risk “The COVID-19 pandemic has underscored that if we can’t reach the most vulnerable, all of us are at risk. The last mile is about ensuring equity in access to quality health care for all, including the most difficult-to-reach and neglected populations. Inequality in global health is as serious as any disease. Without interventions that reach the most vulnerable, it will be impossible to eliminate deadly and debilit

Scientists and government pushing for ways to make mRNA vaccines here

Scientists and government pushing for ways to make mRNA vaccines here Normal text size Advertisement The federal government is working with the biotech industry on ways to establish large-scale mRNA vaccine manufacturing in Australia as a group of senior scientists work on a parallel plan to enable local production of the cutting-edge jabs. The mRNA coronavirus vaccines from Pfizer and Moderna yielded remarkably strong results in clinical trials and are expected to be much easier to reconfigured to cover new viral variants than more conventional inoculations such as AstraZeneca’s, which is being made in Australia by CSL. Harry Al-Wassiti (L) and Colin Pouton are working on a COVID-19 vaccine at Monash University.

New Report Reveals that R&D Partnerships Serving Neglected Communities have Produced Dozens of Life-Saving Innovations Since 2010

(2) Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development NEW YORK, Jan. 28, 2021 /PRNewswire/ The public-private initiatives that contributed to COVID-19 vaccine and drug development have showcased a model for accelerating biomedical innovation. However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit. Over the last decade, such alliances have produced a wide assortment of life-saving technologies targeting diseases that afflict billions in low-income countries, according to a new report from a group of 12 product development partnerships (PDPs) that assesses their impact and future potential.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.